Ausencia de asociación entre síndrome metabólico y síntomas depresivos en adultos colombianos
Background: There is a possible association depressive symptoms (DS) and metabolic syndrome (MS), to the extent that treating one condition improves the other. Aim: To estimate the association between MS and DS among the employees of a medical school. Material and methods: Cross sectional study of 1...
Guardado en:
| Autores principales: | , , , , , , , , , |
|---|---|
| Lenguaje: | Spanish / Castilian |
| Publicado: |
Sociedad Médica de Santiago
2007
|
| Materias: | |
| Acceso en línea: | http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872007000800005 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| Sumario: | Background: There is a possible association depressive symptoms (DS) and metabolic syndrome (MS), to the extent that treating one condition improves the other. Aim: To estimate the association between MS and DS among the employees of a medical school. Material and methods: Cross sectional study of 159 people aged 41±11 years (88 men). MS was evaluated according to International Diabetes Federation (IDF), National Cholesterol Education Program (NCEP)ZAdult Treatment Panel III (ATP-III) and ATP-IIIa criteria and the depression questionnaire of the Center for Epidemiológica! Studies (CES-D) was used for DS. A multivariate logistic regression was performed adjusting for age and gender. Results: The prevalence of MS according to ATP-III was 13.2% (95% CI: 8.4-19.5), to ATP-IIIa was 34.0% (95% CI: 26.6-41.9) and to IDF was 33.3% (95% CI: 26.1-41.2). The prevalence of clinically relevant SD was 15.1% (95% CI: 9.9-21.6). No significant association was found between DS and MS according to the different criteria: ATP-III OR 1.30 (95% CI: 0.40-4.24), ATP-IIIa OR 0.94 (95% CI: 0.37-2.33), IDF OR 1.20 (95% CI: 0.49-2.95). Conclusions: In this series, no association was observed between MS and depression (Rev Méd Chile 2007; 135: 990-6) |
|---|